114 related articles for article (PubMed ID: 32907338)
1. An Improved 3-(4,5-Dimethylthiazol-2-yl)-5-(3-Carboxymethoxyphenyl)-2-(4-Sulfophenyl)-2H-Tetrazolium Proliferation Assay to Overcome the Interference of Hydralazine.
Wang Y; Nguyen DT; Yang G; Anesi J; Chai Z; Charchar F; Golledge J
Assay Drug Dev Technol; 2020; 18(8):379-384. PubMed ID: 32907338
[No Abstract] [Full Text] [Related]
2. A Modified MTS Proliferation Assay for Suspended Cells to Avoid the Interference by Hydralazine and β-Mercaptoethanol.
Wang Y; Nguyen DT; Yang G; Anesi J; Kelly J; Chai Z; Ahmady F; Charchar F; Golledge J
Assay Drug Dev Technol; 2021 Apr; 19(3):184-190. PubMed ID: 33471568
[No Abstract] [Full Text] [Related]
3. Paradoxical proliferative potential of iron (II) sulphate on cancer cells after the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay.
Kok SH; Gambari R; Chui CH; Lau FY; Cheng GY; Lai PB; Lam WS; Chan AS; Cheng CH; Teo IT; Yu MW; Tang JC; Cheung F; Wong RS
Int J Mol Med; 2007 Jun; 19(6):971-5. PubMed ID: 17487432
[TBL] [Abstract][Full Text] [Related]
4. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols.
Wang P; Henning SM; Heber D
PLoS One; 2010 Apr; 5(4):e10202. PubMed ID: 20419137
[TBL] [Abstract][Full Text] [Related]
5. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines.
Buttke TM; McCubrey JA; Owen TC
J Immunol Methods; 1993 Jan; 157(1-2):233-40. PubMed ID: 8423368
[TBL] [Abstract][Full Text] [Related]
6. The pyruvic acid analog 3-bromopyruvate interferes with the tetrazolium reagent MTS in the evaluation of cytotoxicity.
Ganapathy-Kanniappan S; Geschwind JF; Kunjithapatham R; Buijs M; Syed LH; Rao PP; Ota S; Vali M
Assay Drug Dev Technol; 2010 Apr; 8(2):258-62. PubMed ID: 20085459
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cytotoxicity of carbon nanoparticles using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) cell viability assay.
Schrand AM; Lin JB; Hussain SM
Methods Mol Biol; 2012; 906():395-402. PubMed ID: 22791451
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay.
McGowan EM; Alling N; Jackson EA; Yagoub D; Haass NK; Allen JD; Martinello-Wilks R
PLoS One; 2011; 6(6):e20623. PubMed ID: 21673993
[TBL] [Abstract][Full Text] [Related]
9. Development of an in vitro reproductive screening assay for novel pharmaceutical compounds.
Edwards V; Markovic E; Matisons J; Young F
Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):63-71. PubMed ID: 18171324
[TBL] [Abstract][Full Text] [Related]
10. A comparison of colorimetric and DNA quantification assays for the assessment of meniscal fibrochondrocyte proliferation in microcarrier culture.
Pabbruwe MB; Stewart K; Chaudhuri JB
Biotechnol Lett; 2005 Oct; 27(19):1451-5. PubMed ID: 16231215
[TBL] [Abstract][Full Text] [Related]
11. Simple and reliable methods to assess hepatocyte viability in bioartificial liver support system matrices.
Sun J; Wang L; Waring MA; Wang C; Woodman KK; Sheil AG
Artif Organs; 1997 May; 21(5):408-13. PubMed ID: 9129774
[TBL] [Abstract][Full Text] [Related]
12. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture.
Cory AH; Owen TC; Barltrop JA; Cory JG
Cancer Commun; 1991 Jul; 3(7):207-12. PubMed ID: 1867954
[TBL] [Abstract][Full Text] [Related]
13. A Pitfall of the 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethonyphenol)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay due to evaporation in wells on the edge of a 96 well plate.
Patel MI; Tuckerman R; Dong Q
Biotechnol Lett; 2005 Jun; 27(11):805-8. PubMed ID: 16086264
[TBL] [Abstract][Full Text] [Related]
14. Use of a soluble tetrazolium compound to assay metabolic activation of intact beta cells.
Segu VB; Li G; Metz SA
Metabolism; 1998 Jul; 47(7):824-30. PubMed ID: 9667229
[TBL] [Abstract][Full Text] [Related]
15. Prediction of chemotherapeutic response in unresectable non-small-cell lung cancer (NSCLC) patients by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2- (4-sulfophenyl)-2H-tetrazolium (MTS) assay.
Chen J; Cheng GH; Chen LP; Pang TY; Wang XL
Asian Pac J Cancer Prev; 2013; 14(5):3057-62. PubMed ID: 23803079
[TBL] [Abstract][Full Text] [Related]
16. MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of interleukin-15: assay qualification, standardization and statistical analysis.
Soman G; Yang X; Jiang H; Giardina S; Vyas V; Mitra G; Yovandich J; Creekmore SP; Waldmann TA; Quiñones O; Alvord WG
J Immunol Methods; 2009 Aug; 348(1-2):83-94. PubMed ID: 19646987
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening platform for anticancer therapeutic drug cytotoxicity.
Sekhon BK; Roubin RH; Tan A; Chan WK; Sze DM
Assay Drug Dev Technol; 2008 Oct; 6(5):711-21. PubMed ID: 19035851
[TBL] [Abstract][Full Text] [Related]
18. A sensitive WST-8-based bioassay for PEGylated granulocyte colony stimulating factor using the NFS-60 cell line.
Tiwari K; Wavdhane M; Haque S; Govender T; Kruger HG; Mishra MK; Chandra R; Tiwari D
Pharm Biol; 2015 Jun; 53(6):849-54. PubMed ID: 25423580
[TBL] [Abstract][Full Text] [Related]
19. Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.
Ganguly S; Bandyopadhyay S; Sarkar A; Chatterjee M
J Microbiol Methods; 2006 Jul; 66(1):79-86. PubMed ID: 16316700
[TBL] [Abstract][Full Text] [Related]
20. Chitosan and platelet-derived growth factor synergistically stimulate cell proliferation in gingival fibroblasts.
Silva D; Arancibia R; Tapia C; Acuña-Rougier C; Diaz-Dosque M; Cáceres M; Martínez J; Smith PC
J Periodontal Res; 2013 Dec; 48(6):677-86. PubMed ID: 23452122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
